Belatacept for kidney transplant recipients

P Masson, L Henderson, JR Chapman… - Cochrane Database …, 2014 - cochranelibrary.com
Background Most people who receive a kidney transplant die from either cardiovascular
disease or cancer before their transplant fails. The most common reason for someone with a …

Range and consistency of outcomes reported in randomized trials conducted in kidney transplant recipients: a systematic review

B Sautenet, A Tong, JR Chapman, AN Warrens… - …, 2018 - journals.lww.com
Background The potential for clinical trials to impact patient care may be limited if the
outcomes reported vary by trial and lack direct relevance to patients. Despite the many trials …

Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi survey with patients, caregivers, and health …

B Sautenet, A Tong, KE Manera, JR Chapman… - …, 2017 - journals.lww.com
Background Inconsistencies in outcome reporting and frequent omission of patient-centered
outcomes can diminish the value of trials in treatment decision making. We identified …

Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative

A Tong, JC Craig, EV Nagler… - Nephrology Dialysis …, 2017 - academic.oup.com
Randomized trials provide the most reliable evidence about the safety and effectiveness of
interventions to improve health care and patient outcomes. Unfortunately, the potential for …

[HTML][HTML] Standardized outcomes in nephrology-transplantation: a global initiative to develop a core outcome set for trials in kidney transplantation

A Tong, K Budde, J Gill, MA Josephson… - Transplantation …, 2016 - journals.lww.com
Background Although advances in treatment have dramatically improved short-term graft
survival and acute rejection in kidney transplant recipients, long-term graft outcomes have …

The consistency and reporting of quality-of-life outcomes in trials of immunosuppressive agents in kidney transplantation: a systematic review and meta-analysis

M Howell, G Wong, RM Turner, HT Tan, A Tong… - American Journal of …, 2016 - Elsevier
Background Shared decision making regarding immunosuppression in kidney
transplantation requires an understanding of effects on quality of life (QoL). Our aim was to …

Establishing a core outcome measure for graft health: a standardized outcomes in nephrology-kidney transplantation (SONG-Tx) consensus workshop report

A Tong, B Sautenet, ED Poggio, KL Lentine… - …, 2018 - journals.lww.com
Background Graft loss, a critically important outcome for transplant recipients, is variably
defined and measured, and incompletely reported in trials. We convened a consensus …

Trial design and endpoints in clinical transplant research

SR Knight, PJ Morris, S Schneeberger… - Transplant …, 2016 - Wiley Online Library
The number of clinical trials in solid organ transplantation is progressively increasing year
on year, but the quality of design and reporting still varies considerably. The constraints on …

Completeness of reporting of adverse events in trials of maintenance immunosuppression in kidney transplantation: a systematic review

M Howell, R Yeo, A Tong, JC Craig… - Nephrology Dialysis …, 2017 - academic.oup.com
Background. Decision-making regarding immunosuppression after transplantation relies on
robust evidence on the benefits and harms of available drugs. We aimed to evaluate the …

[PDF][PDF] Long-term outcome of renal transplantation: a 10-year follow-up of 765 recipients

B Foroncewicz, K Mucha, M Florczak… - Pol. Arch. Intern …, 2019 - ppm.edu.pl
Long‑term outcome of renal transplantation: a 10‑year follow‑up of 765 recipients Page 1
POLISH ARCHIVES OF INTERNAL MEDICINE 2019; 129 (7-8) 476 ORIGINAL ARTICLE …